Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May;18(5):367-369.
doi: 10.1200/OP.22.00213.

Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States

Linda D Bosserman  1 , Narjust Duma  2 , Miguel Villalona-Calero  1 , Gilberto Lopes  3 , Pelin Cinar  4
Affiliations
Editorial

Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States

Linda D Bosserman et al. JCO Oncol Pract. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Linda D. BossermanThis author is a Consultant Editor for JCO Oncology Practice. Journal policy recused the author from having any role in the peer review of this manuscript.Leadership: IntegraConnectStock and Other Ownership Interests: Navigating Cancer, IntegraConnectHonoraria: ElsevierConsulting or Advisory Role: UpToDate, NDP Partners, Bio Ascend LLC, MDL Litigation Committee for Taxotere PlantiffsPatents, Royalties, Other Intellectual Property: UpToDate Narjust DumaConsulting or Advisory Role: AstraZeneca, Pfizer, NeoGenomics Laboratories, Janssen, Bristol Myers Squibb/Medarex, Merck, Mirati TherapeuticsSpeakers' Bureau: MJH Life Sciences Miguel Villalona-CaleroStock and Other Ownership Interests: Moderna TherapeuticsConsulting or Advisory Role: LillySpeakers' Bureau: AmgenResearch Funding: Merck (Inst), Bristol Myers Squibb (Inst), Guardant Health (Inst), Tolero Pharmaceuticals (Inst), Novocure (Inst), Altor BioScience (Inst) Gilberto LopesStock and Other Ownership Interests: Lucence Diagnostics, XilisHonoraria: Boehringer Ingelheim, Blueprint Medicines, AstraZeneca, MerckConsulting or Advisory Role: Pfizer, AstraZenecaResearch Funding: Merck Sharp & Dohme (Inst), EMD Serono (Inst), AstraZeneca (Inst), Blueprint Medicines (Inst), Tesaro (Inst), Bavarian Nordic (Inst), Novartis (Inst), G1 Therapeutics (Inst), Adaptimmune (Inst), BMS (Inst), GlaxoSmithKline (Inst), AbbVie (Inst), Rgenix (Inst), Pfizer (Inst), Roche (Inst), Genentech (Inst), Lilly (Inst), Janssen (Inst), Lucence, Xilis, E.R. Squibb Sons LLCTravel, Accommodations, Expenses: Boehringer Ingelheim, Pfizer, E.R. Squibb Sons LLC, Janssen, Seattle Genetics, Celgene, Ipsen, Pharmacyclics, Merck, AstraZenecaOther Relationship: Mirati Therapeutics Pelin CinarEmployment: Gilead SciencesStock and Other Ownership Interests: Gilead SciencesConsulting or Advisory Role: Astellas PharmaNo other potential conflicts of interest were reported.

Publication types

LinkOut - more resources